Scarica l'app Stockscreener
13.59
1.95%
-0.27
Dopo l'orario di chiusura:
13.59
Precedente Chiudi:
$13.86
Aprire:
$13.82
Volume 24 ore:
566.22K
Relative Volume:
0.77
Capitalizzazione di mercato:
$1.03B
Reddito:
$54.55M
Utile/perdita netta:
$-193.57M
Rapporto P/E:
-4.7024
EPS:
-2.89
Flusso di cassa netto:
$-181.86M
1 W Prestazione:
-4.23%
1M Prestazione:
-24.54%
6M Prestazione:
-44.35%
1 anno Prestazione:
-8.48%
Intervallo 1D:
$13.33
$14.16
Intervallo di 1 settimana:
$13.33
$14.52
Portata 52W:
$11.90
$29.56
Nurix Therapeutics Inc Stock (NRIX) Company Profile
Nome
Nurix Therapeutics Inc
Settore
Industria
Telefono
(415) 660-5320
Indirizzo
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
Confronta NRIX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
13.59 | 1.03B | 54.55M | -193.57M | -181.86M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.01 | 128.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
744.83 | 81.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
571.00 | 34.69B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
233.07 | 30.17B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
242.66 | 26.02B | 3.32B | -860.46M | -1.04B | -8.32 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-10 | Iniziato | BTIG Research | Buy |
| 2024-12-06 | Iniziato | BMO Capital Markets | Outperform |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-10-11 | Iniziato | Jefferies | Buy |
| 2024-09-06 | Ripresa | Robert W. Baird | Outperform |
| 2024-07-31 | Iniziato | Truist | Buy |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2023-03-09 | Iniziato | Barclays | Overweight |
| 2023-02-28 | Iniziato | Oppenheimer | Outperform |
| 2022-10-11 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | Iniziato | Wells Fargo | Equal Weight |
| 2021-12-29 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-14 | Iniziato | SVB Leerink | Outperform |
| 2021-06-04 | Ripresa | Robert W. Baird | Outperform |
| 2021-04-30 | Ripresa | Piper Sandler | Overweight |
| 2021-04-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-04-14 | Iniziato | Berenberg | Buy |
| 2020-11-19 | Iniziato | Robert W. Baird | Outperform |
| 2020-08-18 | Iniziato | JP Morgan | Overweight |
| 2020-08-18 | Iniziato | Needham | Buy |
| 2020-08-18 | Iniziato | Piper Sandler | Overweight |
| 2020-08-18 | Iniziato | Stifel | Buy |
Mostra tutto
Nurix Therapeutics Inc Borsa (NRIX) Ultime notizie
Candriam S.C.A. Reduces Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Insider Selling: Nurix Therapeutics, Inc. (NASDAQ:NRIX) CFO Sells 5,825 Shares of Stock - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Shares Down 6% on Insider Selling - MarketBeat
Brokerages Set Nurix Therapeutics, Inc. (NASDAQ:NRIX) PT at $31.81 - MarketBeat
Nurix Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
Insider Sell Alert: Houte Van Sells Shares of Nurix Therapeutics Inc (NRIX) - GuruFocus.com
Nurix therapeutics CFO Hans van Houte sells $84,387 in stock By Investing.com - Investing.com Canada
Nurix therapeutics CFO Hans van Houte sells $84,387 in stock - Investing.com India
Nurix Therapeutics CFO Sells Shares - TradingView
(NRIX) Trading Report - Stock Traders Daily
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by ARK Investment Management LLC - MarketBeat
Oversold Conditions For Nurix Therapeutics (NRIX) - Nasdaq
Allspring Global Investments Holdings LLC Decreases Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Allspring Global Investments Holdings LLC Reduces Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Analysts Predict How High Nurix Therapeutics Inc (NRIX) Will Go. - Stocks Register
Kymera Therapeutics: Plenty Of Potential, But A Long Way From The Finish Line (KYMR) - Seeking Alpha
Nurix Therapeutics: A Story To Monitor (NASDAQ:NRIX) - Seeking Alpha
Nurix Therapeutics (NRIX) to Release Quarterly Earnings on Thursday - Defense World
Sumitomo Mitsui Trust Group Inc. Has $14.87 Million Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics (NRIX) Projected to Post Earnings on Thursday - MarketBeat
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Strategic Equity Package: Nurix Therapeutics Secures Top Talent with $8.2M Employee Stock Awards - StockTitan
Sumitomo Mitsui Trust Group Inc. Raises Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Nurix Therapeutics (NRIX) Projected to Post Quarterly Earnings on Thursday - Defense World
Nurix Therapeutics Inc [NRIX] Investment Appeal on the Rise - Knox Daily
Nurix Therapeutics Reports Third Quarter Fiscal 2023 Financial Results and Provides a Corporate Update - br.ADVFN.com
Nurix Therapeutics Reports First Quarter Fiscal 2023 Financial Results and Provides a Corporate Update - br.ADVFN.com
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives $31.12 Consensus Price Target from Brokerages - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Stock Price Expected to Rise, Morgan Stanley Analyst Says - MarketBeat
There is no doubt that Nurix Therapeutics Inc (NRIX) ticks all the boxes. - SETE News
Trading Day Triumph: Nurix Therapeutics Inc (NRIX) Ends at 18.59, a -1.90 Surge/Plunge - The Dwinnex
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Morgan Stanley Forecasts Strong Price Appreciation for Nurix Therapeutics (NASDAQ:NRIX) Stock - Defense World
NRIX (Nurix Therapeutics Inc) may reap gains as insiders became active recently - Knox Daily
HC Wainwright Expects Lower Earnings for Nurix Therapeutics - MarketBeat
Nurix Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - The Manila Times
Nurix Therapeutics Officer Sells Shares - TradingView
Nurix Therapeutics, Inc. (NASDAQ:NRIX) CFO Houte Hans Van Sells 2,811 Shares - MarketBeat
Balanced Outlook on Nurix Therapeutics: Hold Rating Amidst Promising Trials and Uncertainties - TipRanks
Nurix Therapeutics Inc Azioni (NRIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.98%
8.97%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):